|
|
|
Registry of biomedical companies:
[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 467 active entries
No.452, 6th Street
Hangzhou 310018
China
Phone: +86-571-88211951
Fax: +86-571-88211907
E-Mail:
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
Description:
Hangzhou Go Top Peptide Biotech is a private, technology-based company, located in Hangzhou, China. We dedicate to provide full services to those worldwide pharmaceutical, cosmetic and biotech companies. We mainly specialize in the process development and manufacturing PEPTIDE , which is with the highest quality available for all research applications ; Besides, we also provide cosmetic peptides and custom peptide synthesis, HPLC purification and bio-test services. We have well-equipped peptide synthesis center covering 5000 sq.ft. with peptide synthesizer 50L, 20L, 5L; several HPLC purification systems with different sizes, and the center also equipped with GMP standard clean room to meet your special needs. Our technical team is experienced in peptide industry for more than 10 years, excellent know-how in peptide chemistry. Each year, we put 20% of sales revenue into R&D, and we also established sound cooperation with research center of universities and institutes. We have critical control on each steps from procurement, re-test of RM, peptide synthesis, purification, lyophilization, packing and final delivery. Our company is promised to provide in time services and high quality products to each valuable partners! Main peptides: Eptifibatide, Argireline (Cosmetics) , Oxytocin , Leuprorelin, Octreotide, Liraglutide, Thymosin β4, Thymosin a1, Linaclotide... We also provide Custom Peptide Synthesis services , welcome to send inquiry to sales@gotopbio.com
Selected Categories:
Last update of this entry: February 28, 2017
|